bioMerieux Competitors and Similar CompaniesClear all
bioMerieux's competitors and similar companies include Danaher, QIAGEN, Bio-Rad and VWR.
 bioMerieux bioMérieux (formerly known as B-D Mérieux) is a company that develops and manufactures in vitro diagnostic systems. |  Danaher Danaher (formerly known as Diversified Mortgage Investors) is a life sciences and diagnostics company that manages and operates its group companies. |  Bio-Rad Bio-Rad Laboratories is a company that develops, manufactures, and sells life science research and clinical diagnostics products.
| |||
Founding Date | Founding Date 1963 | Founding Date 1984 | Founding Date 1984 | Founding Date 1952 | Founding Date 1852 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Lyon, FR HQ Dely Ibrahim, DZ Buenos Aires, AR Buenos Aires, AR North Ryde, AU North Ryde, AU Wien, AT see more | Locations Washington, US HQ Mount Waverley, AU Vienna, AT Ghent, BE Sao Paolo, BR Vancouver, CA Shanghai, CN see more | Locations Venlo, NL HQ Clayton, AU São Paulo, BR Toronto, CA Beijing, CN Guangzhou, CN Shanghai, CN see more | Locations Hercules, US HQ South Granville, AU South Granville, AU Wien, AT Lokeren, BE Temse, BE São Paulo, BR see more | |
Employees | Employees 14,600 | Employees 60,0002% decrease | Employees 5,6541% decrease | Employees 7,4503% decrease | Employees 5,4796% increase |
Valuation ($) | Valuation ($) 13.7 b | Valuation ($) 175.3 b | Valuation ($) 9.3 b | Valuation ($) 9.2 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) €4b (FY, 2025) | Revenue (est.) $24.6b (FY, 2025) | Revenue (est.) $2.1b (FY, 2025) | Revenue (est.) $2.6b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods €1.3b (FY, 2025) | Cost of goods $10b (FY, 2025) | Cost of goods $577.3m (FY, 2025) | Cost of goods $1.2b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit €2.8b (FY, 2025) | Gross profit $14.5b (FY, 2025) | Gross profit $1.5b (FY, 2025) | Gross profit $1.3b (FY, 2025) | Gross profit N/A |
Net income | Net income €397m (FY, 2025) | Net income $3.6b (FY, 2025) | Net income $437m (FY, 2025) | Net income $759.9m (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
Countries | Countries 160 (FY, 2022) | Countries 50 (FY, 2023) | Countries N/A | Countries 35 (Q1, 2023) | Countries N/A |
Remaining Performance Obligations | Remaining Performance Obligations N/A | Remaining Performance Obligations $4.5b (Q2, 2024) | Remaining Performance Obligations $72m (FY, 2024) | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A |
For sources of this data, please see the company profile
View Company Profiles
Danaher
HQ
Washington, US
Employees
60,000↓ 2% decrease
Danaher (formerly known as Diversified Mortgage Investors) is a life sciences and diagnostics company that manages and operates its group companies.
View company
QIAGEN
HQ
Venlo, NL
Employees
5,654↓ 1% decrease
QIAGEN is a company that provides sample technology solutions.
View companyBio-Rad
HQ
Hercules, US
Employees
7,450↓ 3% decrease
Bio-Rad Laboratories is a company that develops, manufactures, and sells life science research and clinical diagnostics products.
View company
VWR
HQ
Wayne, US
VWR International is a company that provides discovery-to-delivery solutions.
View company